Plasma protein thiol oxidation and carbonyl formation in chronic renal failure

Kidney International

Volumn 58, Issue 6, 2000, Pages 2571-2578

  Himmelfarb, Jonathan ^a,b   McMonagle, Ellen ^a,b   McMenamin, Elizabeth ^a,b  

^a MAINE MEDICAL CENTER   (United States)

^b Maine Medical Center Research Institute   (United States)

Author keywords

Biocompatibility; Carbonyl; Hemodialysis; Oxidant stress; Thiol; Uremia

Indexed keywords

AMINE; CARBONYL DERIVATIVE; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; PLASMA PROTEIN; THIOL;

ARTICLE; BIOCOMPATIBILITY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; OXIDATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; UREMIA;

EID: 0033667376     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00443.x     Document Type: Article

References (62)

1. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy
2. Determinants of albumin concentration in hemodialysis patients
3. Albumin synthesis, catabolism and distribution in dialysis patients
4. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients
5. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
6. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
7. Acute-phase response predicts erythropoietin resistance in hemodialysis
8. Biological basis of hypoalbuminemia in ESRD
9. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
10. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
11. Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients
12. Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients
13. Oxidative stress in chronic renal failure
14. Physiopathology of the oxidative stress and its implications in uremia and dialysis
15. Oxidative stress during dialysis: Effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes
16. An overview of haemodialysis and oxidative stress
17. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure: Evidence of increased oxidative stress in malnourished patients
18. Oxidative stress in haemodialysis
19. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
20. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy
21. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors
22. Increased susceptibility to membrane lipid peroxidation in renal failure
23. No direct evidence of increased lipid peroxidation in hemodialysis patients
24. Oxidation of low density lipoproteins from patients with renal failure or renal transplants
25. Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis
26. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
27. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications
28. Phatocytic cell function as an index of biocompatibility
29. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency
30. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis
31. The effects of dialyzer reuse on plasma antioxidative mechanisms in patients on regular hemodialysis treatment
32. Plasma levels of main granulocyte components during hemodialysis: Comparison of new and reused dialyzers
33. Biocompatibility of dialysis membranes
34. Tissue sulfhydryl groups
35. Antioxidant protection against hypochlorous acid in human plasma
36. Ellman's reagent: 5,5'-Dithiobis (2-nitrobenzoic acid): A reexamination
37. Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid
38. Protein carbonyl measurement by a sensitive ELISA method
39. Protein carbonyl measurement by enzyme-linked immunosorbent assay
40. Carbonyl assays for determination of oxidatively modified proteins
41. Fluorometric assay of proteins in the nanogram range
42. Protein damage and degradation by oxygen radicals. II. Modification of amino acids
43. On the action of hypochlorite in human serum albumin
44. Epidemiology of cardiovascular disease in chronic renal disease
45. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
46. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure
47. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure
48. Protein oxidation in hemodialysis and kidney transplantation
49. Lipofuscin products, lipid peroxides and aluminum accumulation in red blood cells of hemodialyzed patients
50. Free oxygen species metabolism during hemodialysis with different membranes
51. Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron
52. Ferritin-dependent lipid peroxidation by stimulated neutrophils: Inhibition by myeloperoxidase-derived hypochlorous acid but not by endogenous lactoferrin
53. Mass spectrometric quantification of amino acid oxidation products in protein: Insights into pathways that promote LDL oxidation in the human artery wall
54. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders
55. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
56. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
57. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
58. Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: A novel pathway in atherogenesis
59. Profound neutropenia during the early phase of hemodialysis
60. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis
61. Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes
62. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis